DAROL: Darolutamide Observational Study in non-metastatic castration-resistant prostate cancer patients

Research Grant

Duke Scholars

Principal Investigator Andrew John Armstrong Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Bayer Healthcare Pharmaceuticals Inc

Start Date

July 9, 2021

End Date

April 22, 2026

Administered By

Duke Cancer Institute

Awarded By

Bayer Healthcare Pharmaceuticals Inc

Start Date

July 9, 2021

End Date

April 22, 2026